Nicola Gullick

2.3k total citations
57 papers, 1.3k citations indexed

About

Nicola Gullick is a scholar working on Rheumatology, Immunology and Hematology. According to data from OpenAlex, Nicola Gullick has authored 57 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 28 papers in Immunology and 14 papers in Hematology. Recurrent topics in Nicola Gullick's work include Rheumatoid Arthritis Research and Therapies (26 papers), Psoriasis: Treatment and Pathogenesis (25 papers) and Spondyloarthritis Studies and Treatments (23 papers). Nicola Gullick is often cited by papers focused on Rheumatoid Arthritis Research and Therapies (26 papers), Psoriasis: Treatment and Pathogenesis (25 papers) and Spondyloarthritis Studies and Treatments (23 papers). Nicola Gullick collaborates with scholars based in United Kingdom, Canada and Netherlands. Nicola Gullick's co-authors include Bruce Kirkham, Leonie S. Taams, Hayley G. Evans, David L. Scott, Gina Walter, Bina Menon, Toby Garrood, Megha Rajasekhar, Stephen Kelly and Costantino Pitzalis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Nicola Gullick

51 papers receiving 1.2k citations

Peers

Countries citing papers authored by Nicola Gullick

Since Specialization

Citations

This map shows the geographic impact of Nicola Gullick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicola Gullick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicola Gullick more than expected).

Fields of papers citing papers by Nicola Gullick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicola Gullick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicola Gullick. The network helps show where Nicola Gullick may publish in the future.

Co-authorship network of co-authors of Nicola Gullick

This figure shows the co-authorship network connecting the top 25 collaborators of Nicola Gullick. A scholar is included among the top collaborators of Nicola Gullick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicola Gullick. Nicola Gullick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The therapeutic potential for JAK inhibitors for immune-related adverse events from checkpoint inhibitors: a review of the literature 2025 ·Lara D. Veeken ·Deepak Nagra, (unknown), (unknown), Chris Wincup, Arti Mahto, (unknown), (unknown), Maryam Adas, (unknown), Mark Russell, Katie Bechman, (unknown), (unknown), Nicola Gullick, James Galloway	2
2	The Analgesic Efficacy of Therapies Used for Complex Regional Pain Syndrome: A Systematic Review 2025 ·Cureus ·(unknown), (unknown), Nicola Gullick	0
3	The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial 2024 ·Therapeutic Advances in Musculoskeletal Disease ·Marion Watson, William Tillett, Deepak R. Jadon, M. Sofia Massa, (unknown), Nicola Gullick, Ines Rombach, (unknown), Laura Tucker, Laura C. Coates	1
4	Comparative early effectiveness across 14 PsA drugs and 5 classes of PsA treatment: 3-month results from the PRO-SPIRIT study 2024 ·RMD Open ·Lars Erik Kristensen, (unknown), Marcus Ngantcha, Jacques Morel, (unknown), William Tillett, Rieke Alten, Vinod Chandran, (unknown), Baojin Zhu, D. Glenn Kennedy, (unknown), Nicola Gullick, (unknown), (unknown), Inmaculada de la Torre, Dennis McGonagle	2
5	AB1115 STUDY DESIGN AND FULL BASELINE SAMPLE CHARACTERISTICS OF PATIENTS FROM THE 24-MONTH MULTINATIONAL PROSPECTIVE PSORIATIC ARTHRITIS OBSERVATIONAL STUDY OF PERSISTENCE OF TREATMENT (PRO-SPIRIT) 2023 ·Annals of the Rheumatic Diseases ·Jacques Morel, Ennio Lubrano, William Tillett, Rieke Alten, Lars Erik Kristensen, Vinod Chandran, Tamás Treuer, (unknown), (unknown), (unknown), Nicola Gullick	1
6	Management of Psoriatic Arthritis in Patients With Comorbidities: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations 2022 ·The Journal of Rheumatology ·Cristiano Campanholo, Ajesh B. Maharaj, (unknown), Luisa Costa, Kurt de Vlam, Nicola Gullick, Majed Khraishi, Mitsumasa Kishimoto, Natalia Palmou‐Fontana, Soumya M. Reddy, Raffaele Scarpa, (unknown), Gleison Vieira Duarte, Devy Zisman, Daniëlle van der Windt, Mehmet Tuncay Duruöz, Alexis Ogdie	20
7	Executive summary: The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs 2022 ·Lara D. Veeken ·Laura Tucker, Alexander Allen, David Chandler, Coziana Ciurtin, Andrew D. Dick, Amy Foulkes, Nicola Gullick, Philip Helliwell, Deepak R. Jadon, Gareth T. Jones, Stuart Kyle, Vishnu Madhok, Neil McHugh, Andrew Parkinson, Tim Raine, Stefan Siebert, Catherine Smith, William Tillett, Laura C. Coates	3
8	The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs 2022 ·Lara D. Veeken ·Laura Tucker, Alexander Allen, David Chandler, Coziana Ciurtin, Andrew D. Dick, Amy Foulkes, Nicola Gullick, Philip Helliwell, Deepak R. Jadon, Gareth T. Jones, Stuart Kyle, Vishnu Madhok, Neil McHugh, Andrew Parkinson, Tim Raine, Stefan Siebert, Catherine Smith, William Tillett, Laura C. Coates	9
9	Patients’ perspectives of telemedicine appointments for psoriatic arthritis during the COVID-19 pandemic: results of a patient-driven pilot survey 2022 ·BMC Rheumatology ·Hannah Jethwa, Melanie Brooke, Andrew Parkinson, Emma Dures, Nicola Gullick	5
10	Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for adults with psoriatic arthritis—study protocol for the MONITOR-PsA study, a trials within cohorts study design 2021 ·Trials ·Ines Rombach, William Tillett, Deepak R. Jadon, Laura Tucker, Marion Watson, Anne Francis, (unknown), (unknown), Melina Dritsaki, Susan Dutton, Hussein Al‐Mossawi, Nicola Gullick, Ben Thompson, Laura C. Coates	8
11	A first in disease phase 2A trial of granulocyte monocyte colony stimulating factor neutralisation for axial spondyloarthritis (NAMASTE study) 2021 ·Clinical and Experimental Rheumatology ·Hussein Al‐Mossawi, Chris Worth, (unknown), Patrícia Maria Abreu Machado, B Fisher, Alicia Chan, Karl Gaffney, Nicola Gullick, Jon Packham, Raj Sengupta, T. H. Corn, (unknown), Peggy Taylor, Paul Bowness	0
12	Treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs: British Society for Rheumatology guideline scope 2020 ·Lara D. Veeken ·William Tillett, Alexander Allen, Laura Tucker, David Chandler, Coziana Ciurtin, (unknown), Andrew D. Dick, Amy Foulkes, Nicola Gullick, Philip Helliwell, Deepak R. Jadon, Gareth T. Jones, Stuart Kyle, Vishnu Madhok, Neil McHugh, Andrew Parkinson, Tim Raine, Stefan Siebert, Catherine Smith, Laura C. Coates	3
13	Psoriatic disease and body composition: A systematic review and narrative synthesis 2020 ·PLoS ONE ·(unknown), Nicola Gullick, Charles Hutchinson, Thomas M. Barber	31
14	Real world long-term impact of intensive treatment on disease activity, disability and health-related quality of life in rheumatoid arthritis 2019 ·BMC Rheumatology ·(unknown), Nicola Gullick, Fowzia Ibrahim, Ian C. Scott, Alexandra Vincent, Andrew P. Cope, Toby Garrood, G S Panayi, David L. Scott, Bruce Kirkham	24
15	Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound 2016 ·BMC Musculoskeletal Disorders ·(unknown), (unknown), (unknown), Sujith Subesinghe, Nicola Gullick, Bruce Kirkham, Toby Garrood	26
16	TNF-α blockade induces IL-10 expression in human CD4+ T cells 2014 ·Nature Communications ·Hayley G. Evans, Urmas Roostalu, Gina Walter, Nicola Gullick, Klaus Stensgaard Frederiksen, Ceri A. Roberts, Jonathan Sumner, Dominique Baeten, Jens Gerwien, Andrew P. Cope, Frédéric Geissmann, Bruce Kirkham, Leonie S. Taams	97
17	Drug therapy of inflammatory arthritis 2012 ·Clinical Medicine ·Nicola Gullick, David L. Scott	9
18	Interaction with activated monocytes enhances cytokine expression and suppressive activity of human CD4+CD45ro+CD25+CD127^low regulatory T cells 2012 ·Arthritis & Rheumatism ·Gina Walter, Hayley G. Evans, Bina Menon, Nicola Gullick, Bruce Kirkham, Andrew P. Cope, Frédéric Geissmann, Leonie S. Taams	69
19	Co-morbidities in established rheumatoid arthritis 2011 ·Best Practice & Research Clinical Rheumatology ·Nicola Gullick, David L. Scott	86
20	Linking Power Doppler Ultrasound to the Presence of Th17 Cells in the Rheumatoid Arthritis Joint 2010 ·PLoS ONE ·Nicola Gullick, Hayley G. Evans, Leigh D Church, (unknown), Andrew Filer, Bruce Kirkham, Leonie S. Taams	60

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact